anonymous
Guest
anonymous
Guest
could someone please provide a current status of this division? Culture, opportunity to make quality money, obtainable quotas, management, pipeline, etc. appreciate the info in advance.
depends on what you think is quality money. They have some tough competition for Arista coming out in 2017 so that should hurt the biosurgery reps big time. Don't know what is in their pipeline.